Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AUGenomics is a San Diego-based contract research organization (CRO) that specializes in high-throughput next-generation sequencing (NGS) services. The company provides a comprehensive suite of genomic solutions, including whole genome sequencing, RNA-seq, and single-cell analysis, primarily utilizing Illumina's advanced sequencing platforms. AUGenomics serves a diverse clientele across the biotechnology, pharmaceutical, and academic sectors, focusing on delivering rapid turnaround times and high-quality, research-ready data. Their service model includes end-to-end support, from sample preparation and library construction to sophisticated bioinformatics analysis. By offering direct access to their scientific team, AUGenomics ensures that researchers can optimize their experimental designs for maximum discovery potential. The company is positioned as a key partner for organizations requiring scalable and cost-effective genomic data to advance their R&D programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AUGenomics.